14 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
knowingly and willfully soliciting, offering, receiving, or providing any remuneration (including any kickback, bribe, or certain rebate), directly
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
soliciting, offering, receiving, or providing any remuneration (including any kickback, bribe, or certain rebate), directly or indirectly, overtly
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
knowingly and willfully soliciting, offering, receiving, or providing any remuneration (including any kickback, bribe, or certain rebate), directly
S-1/A
EX-1.1
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
other applicable anti-bribery or anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe
S-1
6p00a2ipoujfhe1s0pwc
25 Aug 23
IPO registration
5:03pm
DRS/A
yx14sotfi6w2atqm
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
k5s8c8v0oo8
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
9xwz8 5jmkbtmj
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
tvu0dkevtm5fz7fpgqwe
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
3hpyg8u5p y2tbw1
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
k3dq5f
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
eiegyq4snnprre
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
b4c94ah0qn gp6ru
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next